DOI: 10.1016/S2173-5794(10)70017-7

Intravitreal dexamethasone as an enhancer for the anti-VEGF treatment in neovascular ARMD: Recovering an old ally

Dexametasona intravítrea como potenciador del tratamiento anti-VEGF en la degeneración macular asociada a la edad neovascular: recuperando un viejo aliado

Descargar PDF

R. Gallego-Pinazoa, C. Marín-Lambíesa, F. Marín-Olmosb, R. Martínezb, R. Fonsc, M.L. Díaz-Llopisa,d,e

a Ophthalmology Service, University Hospital La Fe, Valencia, Spain

b Ophthalmology Service, University Clinic Hospital, Valencia, Spain

c Ophthalmology Service, Lluís Alcanyís Hospital, Xàtiva, Valencia, Spain

d Medicine College, University of Valencia, Spain

e Biomedical Research Centre in the Rare Diseases Network (CIBERER), Valencia, Spain